Allworth Financial LP Acquires 1,409 Shares of Maximus, Inc. (NYSE:MMS)

Allworth Financial LP boosted its holdings in shares of Maximus, Inc. (NYSE:MMSFree Report) by 1,638.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,495 shares of the health services provider’s stock after acquiring an additional 1,409 shares during the quarter. Allworth Financial LP’s holdings in Maximus were worth $116,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Nordea Investment Management AB acquired a new position in Maximus during the fourth quarter valued at approximately $4,618,000. Fort Washington Investment Advisors Inc. OH grew its holdings in Maximus by 39.1% during the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider’s stock valued at $22,132,000 after purchasing an additional 83,390 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new position in Maximus during the fourth quarter valued at approximately $1,113,000. Versor Investments LP grew its holdings in Maximus by 213.5% during the third quarter. Versor Investments LP now owns 8,500 shares of the health services provider’s stock valued at $792,000 after purchasing an additional 5,789 shares during the last quarter. Finally, Legato Capital Management LLC grew its holdings in Maximus by 33.9% during the fourth quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider’s stock valued at $2,399,000 after purchasing an additional 8,138 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have commented on the company. StockNews.com downgraded Maximus from a “buy” rating to a “hold” rating in a report on Friday, February 14th. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective on the stock in a research note on Thursday, January 2nd.

View Our Latest Research Report on MMS

Insiders Place Their Bets

In other Maximus news, Director Raymond B. Ruddy purchased 3,490 shares of the firm’s stock in a transaction on Thursday, December 12th. The shares were purchased at an average price of $71.46 per share, for a total transaction of $249,395.40. Following the completion of the purchase, the director now directly owns 112,520 shares of the company’s stock, valued at approximately $8,040,679.20. This represents a 3.20 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Michelle F. Link sold 2,208 shares of Maximus stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the sale, the insider now owns 6,567 shares in the company, valued at $484,841.61. This represents a 25.16 % decrease in their position. The disclosure for this sale can be found here. Insiders have acquired 7,063 shares of company stock worth $502,017 over the last 90 days. Corporate insiders own 1.60% of the company’s stock.

Maximus Trading Down 1.2 %

Shares of Maximus stock opened at $65.95 on Monday. The company’s fifty day simple moving average is $73.79 and its 200-day simple moving average is $81.63. The company has a market cap of $3.73 billion, a price-to-earnings ratio of 14.18 and a beta of 0.72. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a 1 year low of $64.53 and a 1 year high of $93.97.

Maximus (NYSE:MMSGet Free Report) last announced its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, sell-side analysts expect that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Saturday, February 15th will be paid a dividend of $0.30 per share. The ex-dividend date is Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.82%. Maximus’s dividend payout ratio is currently 25.81%.

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Recommended Stories

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.